Wondering if Abbott Laboratories is undervalued, fairly priced, or perhaps even a hidden bargain? You are not alone, as many ...

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

Abbott Laboratories has won a legal case claiming its Similac infant formula caused the death of a baby from necrotizing ...

The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...

The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.

Abbott Laboratories Inc. convinced a federal judge that there wasn’t a feasible alternative design to a form of infant formula that parents said caused a fatal disease to their preterm child.

Abbott Laboratories (NYSE:ABT) has significantly outperformed the broader S&P 500 index this year, with its stock price rising 18% compared to the S&P 500’s 6% gain. This strong performance stems from ...

Abbott Laboratories (NYSE:ABT) is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

The court said D.B.'s parents could not meet the threshold for a product liability claim under Louisiana's Products Liability ...

Walmart will become the first U.S. retailer to sell Abbott Laboratories' over-the-counter continuous glucose monitor Lingo in ...